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Introduction 
• Sarcoidosis is a noncaseating, granulomatous disease 
that primarily affects the lungs and skin, but can include 
other organ systems.  
 
• Central nervous system (CNS) involvement is rare, 
affecting 5 to 13% of patients, with many cases being 
subclinical. 
 
Case Presentation 
• 38 year old African American female, with a known history 
of sarcoidosis, presented with refractory trigeminal 
neuralgia. 
 
• Magnetic Resonance Imaging (MRI) head was done, 
revealing a 1.5 cm x 0.6 cm x 1.1 cm mass in the left 
Meckel’s cave (Figure 1). 
 
• A partial craniotomy was performed and the mass was 
excised.   
 
Pathology and Laboratory  Results 
• Frozen sections showed noncaseating, granulomatous 
inflammation, suggestive for sarcoidosis (Figure 2). 
 
• Tissue stains for acid fast bacilli and fungi were negative. 
 
• Serology studies, including Human Immunodeficiency 
Virus (HIV), Quantiferon Gold, and Antinuclear Antibody 
(ANA) were negative. Angiotensin Converting Enzyme 
(ACE) on serum was normal. 
 
Clinical Outcome 
• The patient’s symptoms improved dramatically post 
operatively. 
 
• The patient was dismissed with a tapering dose of 
steroids. 
 
• Outpatient follow up with a rheumatologist was 
scheduled. 
Figure 1: MRI T1 with gadolinium showing  an enhancing 
lesion in the region of Meckel’s cave. 
Figure 2:  Low powered image (above) and high-power 
image (below) of inflammatory cells with multinucleated giant 
cells, characteristic of noncaseating, granuloma formation.  
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Discussion 
• Neurosarcoidosis presents within two years of the initial 
diagnosis of sarcoidosis, most commonly affecting cranial 
nerve (CN) VII. 
 
• There are very few case reports of neurosarcoidosis 
presenting as trigeminal neuralgia, a unilateral, sharp, 
intermittent pain resulting from compression of one or 
more of the CN V branches. 
 
• Laboratory evaluation is limited; analysis of cerebral 
spinal fluid (CSF) can help rule out infectious etiologies. 
 
• ACE is elevated in the serum of 29-60% of patients, but 
absence of elevation does not rule out neurosarcoidosis. 
 
• MRI is the most common imaging modality used to 
investigate possible neurosarcoidosis. 
 
• The gold standard for diagnosis is histological 
examination. 
 
• Treatment includes steroids or immunomodulators. 
 
Conclusion 
• Although rare, neurosarcoidosis should be a differential 
diagnosis for a patient with known sarcoidosis presenting 
with neurological symptoms. 
